Typical administration periods range from 5 to
Exacerbations are a hallmark feature of COPD and contribute to morbidity and mortality
The guideline, Pharmacologic Management of COPD Exacerbations, was developed by the American Academy of Family Physicians and approved by the Board of Directors in April
Bates J, Francis NA, White P, et al
Use unscented cleaning products in
2
A 2013 Cochrane review of seven RCTs (N = 3,170) examined whether the use of prophylactic antibiotics in patients with COPD reduces exacerbations or improves quality of life
However, the majority of patients avoided treatment failure even in the placebo group (58%), suggesting that not all exacerbations require treatment with antibiotics
Fluoroquinolone antibiotics: In January 2024, the MHRA published a Drug Safety Update on fluoroquinolone antibiotics
COPD is the name given to a group of long-term lung diseases
d
A study was eligible for inclusion if it met the following criteria: 1
Patients (n=511) were enrolled into a randomised double-blind multicentric study comparing the exacerbation-free interval (EFI), efficacy and safety of
Moderate: SABD + antibiotics +/- oral corticosteroids
Patients with chronic obstructive pulmonary disease (COPD) are at increased risk for developing community-acquired pneumonia (CAP) compared to non-COPD patients, and pneumonia itself may lead to a worse outcome of an exacerbation than a simple bronchitic worsening
increased sputum Management of COPD Exacerbations ANN E